Additional file 1 of A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma

Autor: Booth, Stephen W., Eyre, Toby A., Whittaker, John, Campo, Leticia, Wang, Lai Mun, Soilleux, Elizabeth, Royston, Daniel, Rees, Gabrielle, Kesavan, Murali, Hildyard, Catherine, Kazmi, Farasat, La Thangue, Nick, Kerr, David, Middleton, Mark R., Collins, Graham P.
Rok vydání: 2021
DOI: 10.6084/m9.figshare.15047655.v1
Popis: Additional file 1: Table S1. All treatment emergent adverse events categorised and graded according to CTCAE version 4.03. Table S2. HR23B score data for all treated patients. Figure S1. Progression-free Survival on CXD101.
Databáze: OpenAIRE